EverQuote, Inc. (NASDAQ:EVER – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $24.1667.
Several equities research analysts have recently commented on EVER shares. B. Riley Financial reduced their target price on EverQuote from $36.00 to $30.00 and set a “buy” rating for the company in a report on Tuesday, February 24th. Weiss Ratings cut EverQuote from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 1st. JPMorgan Chase & Co. boosted their price objective on EverQuote from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Tuesday, May 5th. Craig Hallum reaffirmed a “buy” rating and set a $20.00 price objective on shares of EverQuote in a research note on Tuesday, February 24th. Finally, Canaccord Genuity Group decreased their target price on shares of EverQuote from $33.00 to $28.00 and set a “buy” rating for the company in a report on Tuesday, February 24th.
Get Our Latest Stock Report on EVER
Insider Activity
Institutional Trading of EverQuote
Hedge funds have recently modified their holdings of the business. Comerica Bank boosted its position in shares of EverQuote by 235.4% in the third quarter. Comerica Bank now owns 1,100 shares of the company’s stock worth $25,000 after buying an additional 772 shares during the period. Versant Capital Management Inc raised its position in EverQuote by 108.9% during the third quarter. Versant Capital Management Inc now owns 1,153 shares of the company’s stock valued at $26,000 after buying an additional 601 shares during the period. Signature Equity Partners LLC raised its position in EverQuote by 65.5% during the first quarter. Signature Equity Partners LLC now owns 2,127 shares of the company’s stock valued at $33,000 after buying an additional 842 shares during the period. NewEdge Advisors LLC purchased a new stake in EverQuote in the 3rd quarter worth about $52,000. Finally, Clearstead Advisors LLC lifted its stake in EverQuote by 70.5% in the 4th quarter. Clearstead Advisors LLC now owns 1,997 shares of the company’s stock worth $54,000 after acquiring an additional 826 shares in the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.
EverQuote Stock Performance
NASDAQ EVER opened at $17.48 on Friday. EverQuote has a 1 year low of $13.88 and a 1 year high of $28.73. The business’s fifty day moving average is $16.53 and its two-hundred day moving average is $20.78. The stock has a market capitalization of $629.80 million, a P/E ratio of 5.95 and a beta of 0.56.
EverQuote (NASDAQ:EVER – Get Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.08. The business had revenue of $190.85 million during the quarter, compared to analyst estimates of $180.10 million. EverQuote had a return on equity of 53.39% and a net margin of 15.35%.The company’s revenue was up 14.6% compared to the same quarter last year. During the same period last year, the company posted $0.21 EPS. On average, research analysts forecast that EverQuote will post 2.03 earnings per share for the current year.
EverQuote Company Profile
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
Recommended Stories
- Five stocks we like better than EverQuote
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
